Le Lézard
Classified in: Health, Science and technology

Health Education Platform, Osmosis, Secures Greycroft As Anchor Investor To Transform Everyone Into Students of Health and Wellness


BALTIMORE, Dec. 12, 2018 /PRNewswire/ -- Osmosis, the lead medical education platform dedicated to helping current and future healthcare professionals and caregivers learn and retain information, has announced Greycroft as an anchor investor. The educational platform, founded by two medical students at Johns Hopkins University. has 50 million views to date, an audience of over 850,000 on their YouTube channel and over 350,000 registered users, transforming the traditional learning experience for medical and allied health science students and clinicians.

"Osmosis' approach to supplemental education is truly dramatic and has already had significant impact with medical students and institutions around the world -- and, they're just penetrating the surface," said legendary investor Alan Patricof, co-founder of Greycroft, and early investor in Apple, AOL, Huffington Post, theSkimm and others. 

"We created Osmosis as  medical students to solve a problem: learning medicine is difficult because it's vast, dynamic, and high stakes. We quickly realized that this problem is shared by millions of other health professionals and students as well as their patients. That's why our vision is 'Everyone who cares for someone will learn by Osmosis.'," said Shiv Gaglani, CEO and co-founder.

Reports show that up to 80% of medical students are not attending lectures regularly, creating concern over what students are learning and how they are learning it. Osmosis has been implemented by more than two dozen health professional schools globally, from the University of Michigan to Weill Cornell Medical College in Qatar, to enhance active learning inside and outside of the classroom.

"What drew me to Osmosis is the fact that when they created this content to help medical students, the surprise came when consumer adoption really started to grow without anticipating it. I look at disruption and innovation and I see something really powerful happen, even though it's different than expected. It's really phenomenal," said investor Greg Coleman, former President at Buzzfeed.

To learn more about Osmosis, visit: www.osmosis.org.

About Osmosis
Created by medical students from Johns Hopkins and the former Khan Academy Health & Medicine team, Osmosis is a leading and rapidly growing medical education platform used by more than 850,000 current and future health professionals as well as patients and their family members.  Osmosis's mission is to empower the world's clinicians and caregivers with the best learning experience possible. It accomplishes this through an expanding library of more than 1,000 clear & concise educational videos on everything from atrial fibrillation to Zika virus as well as a personalized learning platform that incorporates evidence-based cognitive techniques, machine learning, and gamification to make learning efficient and enjoyable.

About Greycroft

Greycroft is a leading venture capital firm focused on investments in the Internet and mobile markets. With offices in the two media capitals of the world - New York and Los Angeles ? Greycroft is uniquely positioned to serve entrepreneurs who have chosen us as their partners. Greycroft manages $1.3 billion and has made over 150 investments since inception in leading companies including Acorns, Bird, Huffington Post, Maker Studios, Plated, TheRealReal, Trunk Club, and Venmo. For more information please visit http://www.greycroft.com.

Media Contact
Blake Schenerlein
Bevel PR for Osmosis
[email protected]
304-483-1516

SOURCE Osmosis


These press releases may also interest you

at 09:10
StatLab Medical Products ("StatLab"), a leading developer and manufacturer of medical diagnostic supplies and equipment, today announced the acquisition of Scientific Device Laboratory ("SDL"), a Chicago-based manufacturer of printed diagnostic...

at 09:10
Global metalworking fluid, grease, and lubricating oil manufacturers, notably those seeking new, more sustainable lubricants using renewable base oils/high-quality additives for the automotive and electric vehicle (EV) industries, can anticipate new...

at 09:05
LumaBridge, a clinical research organization (CRO) dedicated to discovering, developing, and testing emerging biotechnologies related to cancer therapies, today announced the appointment of Todd Lehman as Chief Executive Officer, President and member...

at 09:05
Ontada®, a McKesson business dedicated to leveraging oncology real-world data and evidence, clinical education, and provider technology, announced the appointment of Jade Cusick as its new Chief Commercial Officer and member of the Ontada leadership...

at 09:05
Artiva Biotherapeutics, Inc., a clinical-stage company whose mission is to deliver broadly accessible, off-the-shelf natural killer (NK) cell-based therapies to patients suffering from devastating autoimmune diseases and cancers, today announced the...

at 09:05
Multiply Labs, a robotics company developing industry-leading automated manufacturing systems to produce individualized drugs, and GenScript Biotech Corporation (GenScript), one of the world's leading providers of life-science research tools and...



News published on and distributed by: